Class I — Serious Health Hazard

Serious health hazard — there is a reasonable probability that use of or exposure to this product will cause serious adverse health consequences or death.

TRUFILL¿ n-Butyl Cyanoacrylate (n-BCA) Liquid Embolic System Recalled by Codman & Shurtleff, Inc. Due to Incorrect instructions for use (IFU).

Date: October 11, 2013
Company: Codman & Shurtleff, Inc.
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Codman & Shurtleff, Inc. directly.

Affected Products

TRUFILL¿ n-Butyl Cyanoacrylate (n-BCA) Liquid Embolic System; Two 1 g tubes of n-BCA, one 10 mL vial of Ethiodized Oil and one 1 g vial of Tantalum Powder Product Code: 631-400; The TRUFILL n-BCA Liquid Embolic System is indicated for the embolization of cerebral arteriovenous malformations (AVMs) when pre-surgical devascularization is desired.

Quantity: 3,860

Why Was This Recalled?

Incorrect instructions for use (IFU).

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About Codman & Shurtleff, Inc.

Codman & Shurtleff, Inc. has 58 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report